BackLiminal Biosciences Overview

Liminal Biosciences Total Assets

Liminal Biosciences's total assets is $32M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$31.80M
55.13% YoYΔ $-39.08M vs prior year quarter

Peer trimmed avg / median

Loading

Liminal Biosciences Total Assets History

Loading

Liminal Biosciences vs. peers: Total Assets Comparison

Loading

Liminal Biosciences Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Liminal Biosciences (LMNL) FAQ

As of the most recent data (June 2023), LMNL shows a total assets of $32M. That compares with $71M in the prior-year period — down 55.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LMNL's total assets is now $32M (was $71M) — a 55.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Liminal Biosciences is outperforming or lagging.

Tracking LMNL's total assets over time shows whether Liminal Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $32M That compares with $71M in the prior-year period — down 55.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Liminal Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $32M) with ownership activity and broader fundamentals.

Liminal Biosciences's total assets is $32M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.